Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement.

Coulette S, Lecler A, Saragoussi E, Zuber K, Savatovsky J, Deschamps R, Gout O, Sabben C, Aboab J, Affortit A, Charbonneau F, Obadia M.

AJNR Am J Neuroradiol. 2019 Jul;40(7):1184-1190. doi: 10.3174/ajnr.A6103. Epub 2019 Jun 27.

PMID:
31248864
2.

Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy.

Lecler A, Charbonneau F, Psimaras D, Metten MA, Gueguen A, Hoang Xuan K, Feuvret L, Savatovsky J.

Eur Radiol. 2018 Oct;28(10):4324-4333. doi: 10.1007/s00330-018-5356-8. Epub 2018 Apr 12.

PMID:
29651771
3.

Multinodular vacuolating and neuronal tumor of the cerebrum.

Badat N, Savatovsky J, Charbonneau F, Collin A, Lecler A.

Neurology. 2017 Jul 18;89(3):304-305. doi: 10.1212/WNL.0000000000004123. No abstract available.

PMID:
28716873
4.

Repeatability of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0 Tesla in orbital lesions.

Lecler A, Savatovsky J, Balvay D, Zmuda M, Sadik JC, Galatoire O, Charbonneau F, Bergès O, Picard H, Fournier L.

Eur Radiol. 2017 Dec;27(12):5094-5103. doi: 10.1007/s00330-017-4933-6. Epub 2017 Jul 4.

5.

Incidence and Prognostic Implications of Late Bleeding After Myocardial Infarction or Unstable Angina According to Treatment Strategy.

Brinkert M, Southern DA, James MT, Knudtson ML, Anderson TJ, Charbonneau F.

Can J Cardiol. 2017 Aug;33(8):998-1005. doi: 10.1016/j.cjca.2017.05.001. Epub 2017 May 5.

PMID:
28669702
6.

TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity.

Lecler A, Obadia M, Savatovsky J, Picard H, Charbonneau F, Menjot de Champfleur N, Naggara O, Carsin B, Amor-Sahli M, Cottier JP, Bensoussan J, Auffray-Calvier E, Varoquaux A, De Gaalon S, Calazel C, Nasr N, Volle G, Jianu DC, Gout O, Bonneville F, Sadik JC.

AJNR Am J Neuroradiol. 2017 Jul;38(7):1391-1398. doi: 10.3174/ajnr.A5214. Epub 2017 May 11.

7.

[Intractable vomiting].

Chehaibou I, Charbonneau F, Deschamps R.

Rev Med Interne. 2015 Jun;36(6):432-4. doi: 10.1016/j.revmed.2014.11.001. Epub 2014 Nov 13. French. No abstract available.

PMID:
25475827
8.

Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials.

Nielsen TH, Diaz Z, Christodoulopoulos R, Charbonneau F, Qureshi S, Rousseau C, Benlimame N, Camlioglu E, Constantin AM, Oros KK, Krumsiek J, Crump M, Morin RD, Cerchietti L, Johnson NA, Petrogiannis-Haliotis T, Miller WH Jr, Assouline SE, Mann KK.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2688-93. doi: 10.1158/1055-9965.EPI-14-0549.

9.

Tumor pathology of the orbit.

Héran F, Bergès O, Blustajn J, Boucenna M, Charbonneau F, Koskas P, Lafitte F, Nau E, Roux P, Sadik JC, Savatovsky J, Williams M.

Diagn Interv Imaging. 2014 Oct;95(10):933-44. doi: 10.1016/j.diii.2014.08.002. Epub 2014 Sep 5. Review.

10.

Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Power LA, Sessink PJ, Gesy K, Charbonneau F.

Hosp Pharm. 2014 Apr;49(4):355-62. doi: 10.1310/hpj4904-355.

11.

No more fear of the cavernous sinuses!

Charbonneau F, Williams M, Lafitte F, Héran F.

Diagn Interv Imaging. 2013 Oct;94(10):1003-16. doi: 10.1016/j.diii.2013.08.012. Epub 2013 Oct 5.

12.

The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort.

Martin BJ, Verma S, Charbonneau F, Title LM, Lonn EM, Anderson TJ.

Obesity (Silver Spring). 2013 Feb;21(2):266-73. doi: 10.1002/oby.20266.

13.

Hyperfrontality and hypoconnectivity during refreshing in schizophrenia.

Grillon ML, Oppenheim C, Varoquaux G, Charbonneau F, Devauchelle AD, Krebs MO, Baylé F, Thirion B, Huron C.

Psychiatry Res. 2013 Mar 30;211(3):226-33. doi: 10.1016/j.pscychresns.2012.09.001. Epub 2012 Nov 5.

14.

CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation.

Tourigny A, Charbonneau F, Xing P, Boukrab R, Rousseau G, St-Arnaud R, Brezniceanu ML.

PLoS One. 2012;7(10):e48652. doi: 10.1371/journal.pone.0048652. Epub 2012 Oct 31.

15.

Diffusion MR imaging of the optic nerve in a patient with giant-cell arteritis and vertebral artery vasculitis.

Biotti D, Savatovski J, Bidot S, Shotar E, Charbonneau F, Obadia M, Gueguen A.

Eur Neurol. 2011;66(2):83-4. doi: 10.1159/000329885. Epub 2011 Jul 21. No abstract available.

PMID:
21778731
16.

Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.

Anderson TJ, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn EM.

Circulation. 2011 Jan 18;123(2):163-9. doi: 10.1161/CIRCULATIONAHA.110.953653. Epub 2011 Jan 3.

PMID:
21200002
17.

Key components of intravenous chemotherapy labeling: a systematic review and practice guideline.

Trudeau M, Green E, Cosby R, Charbonneau F, Easty T, Ko Y, Marchand P, David U, Berger N, Hertz S.

J Oncol Pharm Pract. 2011 Dec;17(4):409-24. doi: 10.1177/1078155210385160. Epub 2010 Sep 27. Review.

PMID:
20876081
18.

Creating synergy in our health system: The challenges of primary angioplasty.

Charbonneau F.

Can J Cardiol. 2009 Nov;25(11):e387-8. No abstract available.

19.

Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis.

Terrier B, Charbonneau F, Touzé E, Berezne A, Pagnoux C, Silvera S, Meder JF, Guillevin L, Oppenheim C, Mouthon L.

J Rheumatol. 2009 Jul;36(7):1486-94. doi: 10.3899/jrheum.081222. Epub 2009 Jun 16.

PMID:
19531752
20.

Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.

Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ.

Am J Cardiol. 2009 Jun 1;103(11):1610-5. doi: 10.1016/j.amjcard.2009.01.376. Epub 2009 Apr 8.

PMID:
19463524
21.

The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.

Yan RT, Yan AT, Anderson TJ, Buithieu J, Charbonneau F, Title L, Verma S, Lonn EM.

Atherosclerosis. 2009 Nov;207(1):232-8. doi: 10.1016/j.atherosclerosis.2009.03.053. Epub 2009 Apr 16.

PMID:
19439301
22.

Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome.

Title LM, Lonn E, Charbonneau F, Fung M, Mather KJ, Verma S, Anderson TJ.

Vasc Med. 2008 Nov;13(4):263-70. doi: 10.1177/1358863X08095154.

PMID:
18940902
23.

[Imaging of acute confusional state].

Brami-Zylberberg F, Charbonneau F, Naggara O, Rodrigo S, Oppenheim C, Pruvo JP, Meder JF.

J Radiol. 2008 Jul-Aug;89(7-8 Pt 1):843-51. French. No abstract available.

PMID:
18772746
24.

The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis.

Anderson T, Charbonneau F, Chan S, Lonn E.

Atherosclerosis. 2008 Oct;200(2):424-31. doi: 10.1016/j.atherosclerosis.2007.12.030. Epub 2008 Feb 8.

PMID:
18262192
25.

Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).

Charbonneau F, Anderson TJ, Title L, Jobin J, Poirier P, Huyhn T, Chan S, Walling A, Hutchison S, Tran T, Lonn E, Buithieu J, Genest J.

Atherosclerosis. 2008 Mar;197(1):420-7. Epub 2007 Aug 1.

PMID:
17673219
26.

[Diffusion tensor imaging and tractography of the brain and spinal cord].

Oppenheim C, Ducreux D, Rodrigo S, Hodel J, Tourdias T, Charbonneau F, Pierrefitte S, Meder J.

J Radiol. 2007 Mar;88(3 Pt 2):510-20. Review. French.

PMID:
17457261
27.

[Congenital absence of a cervical pedicle].

Tourdias T, Charbonneau F, Hodel J, Rodrigo S, Meder JF.

J Neuroradiol. 2006 Dec;33(5):347-8. French. No abstract available.

PMID:
17213763
28.

The effect of iron status on vascular health.

Yunker LM, Parboosingh JS, Conradson HE, Faris P, Bridge PJ, Buithieu J, Title LM, Charbonneau F, Verma S, Lonn EM, Anderson TJ.

Vasc Med. 2006 May;11(2):85-91.

PMID:
16886838
29.

Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.

Worthley MI, Anderson TJ, Traboulsi M, Charbonneau F, Curtis MJ, Hansen JL, Knudtson ML, Spence FP, Goodhart DM.

Heart Lung Circ. 2006 Oct;15(5):300-5. Epub 2006 Jul 28.

PMID:
16877042
30.

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.

Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, Charbonneau F, Cohen E, Curtis M, Buller CE, Mendelsohn FO, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J, Rasmussen C, Kessler PD, Rasmussen HS.

Gene Ther. 2006 Nov;13(21):1503-11. Epub 2006 Jun 22.

PMID:
16791287
31.

Can the measurement of impaired flow-mediated dilation predict in-stent restenosis?

Worthley MI, Charbonneau F, Anderson TJ.

Nat Clin Pract Cardiovasc Med. 2005 May;2(5):238-9. No abstract available.

PMID:
16265504
32.

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.

Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S.

Lancet Oncol. 2005 Nov;6(11):886-98. Review.

PMID:
16257797
33.

[Diagnosis and follow-up of cervical arterial dissections--results of the SFNV-SFNR study].

Charbonneau F, Gauvrit JY, Touze E, Moulin T, Bracard S, Leclerc X, Mas JL, Meder JF.

J Neuroradiol. 2005 Sep;32(4):255-7. French.

PMID:
16237364
34.

The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers.

Verma S, Wang CH, Li SH, Lonn E, Charbonneau F, Title LM, Anderson TJ; FATE Investigators.

Atherosclerosis. 2005 Oct;182(2):361-5. Epub 2005 Mar 23.

PMID:
16159609
35.

Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men.

Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E.

J Am Coll Cardiol. 2005 Jun 21;45(12):1980-6.

36.

Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.

Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, Jobin J, Lonn E, Poirier P, Title L, Walling A, Tran T, Boudreau G, Charbonneau F, Genest J.

Am J Cardiol. 2005 Jan 15;95(2):249-53.

PMID:
15642561
37.

Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals.

Verma S, Wang CH, Lonn E, Charbonneau F, Buithieu J, Title LM, Fung M, Edworthy S, Robertson AC, Anderson TJ; FATE Investigators.

Eur Heart J. 2004 Oct;25(19):1754-60.

PMID:
15451155
38.

Comparison of endothelial function in young men and women with a family history of premature coronary artery disease.

Hamburg NM, Charbonneau F, Gerhard-Herman M, Ganz P, Creager MA.

Am J Cardiol. 2004 Sep 15;94(6):783-5.

PMID:
15374789
39.

Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical Oncologists.

Verma S, Kerr-Cresswell D, Dranitsaris G, Charbonneau F, Trudeau M, Yogendran G, Cesta AM, Clemons M.

Support Care Cancer. 2004 Dec;12(12):852-8. Epub 2004 Aug 21.

PMID:
15322969
40.

Do physicians follow systemic treatment and funding policy guidelines?

Clemons M, Enright K, Cesta A, Charbonneau F, Chow E, Warr D, Kee-Cresswell D, Chang J, Yogendran G, Trudeau M, De Angelis C, Cottrell W, Dranitsaris G.

Can J Clin Pharmacol. 2004 Spring;11(1):e168-78.

PMID:
15300959
41.

Vasospasm and myocardial bridge.

Joyal D, Charbonneau F.

Can J Cardiol. 2003 Nov;19(12):1440-2.

PMID:
14631480
42.

Depression and prognosis following hospital admission because of acute myocardial infarction.

Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, Diodati JG, Charbonneau F, Dupuis R, Pilote L.

CMAJ. 2003 Mar 4;168(5):547-52.

43.

The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study.

Anderson TJ, Roberts AC, Hildebrand K, Conradson HE, Jones C, Bridge P, Edworthy S, Lonn E, Verma S, Charbonneau F.

Can J Cardiol. 2003 Jan;19(1):61-6.

PMID:
12571696
44.

The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension.

Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ.

Hypertension. 2002 Apr;39(4):919-22.

PMID:
11967250
45.

Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography.

Pilote L, Lauzon C, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Lévesque C, Charbonneau F, Pouliot J, Joseph L, Eisenberg MJ.

Arch Intern Med. 2002 Mar 11;162(5):553-9.

PMID:
11871923
46.

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force.

J Am Coll Cardiol. 2002 Jan 16;39(2):257-65. Erratum in: J Am Coll Cardiol 2002 Mar 20;39(6):1082.

47.

Use of measures of endothelial function to stratify risk.

Charbonneau F.

Can J Cardiol. 2001 May;17 Suppl A:18A-21A.

PMID:
11381290
48.

Correlation of endothelial function in large and small arteries in human essential hypertension.

Park JB, Charbonneau F, Schiffrin EL.

J Hypertens. 2001 Mar;19(3):415-20.

PMID:
11288811
49.

Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.

Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.

Can J Cardiol. 2001 Jan;17(1):33-40.

PMID:
11173312

Supplemental Content

Loading ...
Support Center